tiprankstipranks
Acurx Pharmaceuticals (ACXP)
NASDAQ:ACXP
US Market

Acurx Pharmaceuticals (ACXP) Financial Statements

Compare
153 Followers

Acurx Pharmaceuticals Financial Overview

Acurx Pharmaceuticals's market cap is currently $13.33M. The company's EPS TTM is $-1.095; its P/E ratio is ―; Acurx Pharmaceuticals is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -14.58M$ -12.09M$ -12.88M$ -4.60M$ -5.93M
EBITDA$ 0.00$ -12.09M$ 0.00$ -4.60M$ -5.93M
Net Income$ -14.58M$ -12.09M$ -12.68M$ -4.60M$ -5.93M
Balance Sheet
Cash & Short-Term Investments$ 7.47M$ 9.11M$ 12.96M$ 3.18M$ 2.48M
Total Assets$ 7.71M$ 9.38M$ 13.25M$ 3.22M$ 2.53M
Total Debt$ 0.00$ 0.00$ 0.00$ 66.50K$ 0.00
Net Debt$ -7.47M$ -9.11M$ -12.96M$ -3.11M$ -2.48M
Total Liabilities$ 3.04M$ 2.06M$ 843.91K$ 522.43K$ 1.71M
Stockholders' Equity$ 4.67M$ 7.32M$ 12.41M$ 2.70M$ 819.85K
Cash Flow
Free Cash Flow$ -9.80M$ -7.54M$ -5.01M$ -3.35M$ -3.99M
Operating Cash Flow$ -9.80M$ -7.54M$ -5.01M$ -3.35M$ -3.99M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 8.16M$ 3.70M$ 14.80M$ 4.04M$ 4.46M
Currency in USD

Acurx Pharmaceuticals Earnings and Revenue History

Acurx Pharmaceuticals Debt to Assets

Acurx Pharmaceuticals Cash Flow

Acurx Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis